Coeliac disease in the modern era： Severity of small bowel mucosal injury at diagnosis with analysis of clinical correlates and rate of improvement on a gluten free diet

摘要

AIM To analyze the relationships between pre-diagnosis coeliac serology, duodenal histopathology, primary presenting symptoms, coeliac-related comorbidity and response to treatment in a modern cohort with new diagnosis of coeliac disease(CD).METHODS A retrospective cohort study including 99 participants diagnosed with CD between 1999 and 2013. All patients had the following data recorded: baseline characteristics, coeliac serology, small bowel histopathology. A subset of this cohort underwent a repeat small bowel biopsy. Independent associations were assessed with logistic regression.RESULTS The mean age at diagnosis was 43 years(Interquartile range 30-53 years) and 68% of the cohort was female. At diagnosis 49(49%) patients had total villous blunting(MS 3c), 12(12%) had subtotal villous blunting(MS 3b), and 29(29%) had partial villous blunting(MS 3a). The prevalence of symptoms pre diagnosis was not related to the severity of villous blunting(P = 0.490). 87(88%) of the cohort underwent repeat small bowel biopsy after a median of 7 mo(IQR 6-11 mo). 34(39%) patients had biopsy results ≥ MS 3 a which compared to 90(90%) at the initial biopsy. 24(71%) of this group reported adherence to a gluten free diet(GFD). Persistent MS ≥ 3 a at repeat biopsy was not associated with symptoms(P=0.358) or persistent positive coeliac serology(P = 0.485).CONCLUSION Neither symptoms nor serology predict the severity of the small bowel mucosal lesion at CD diagnosis. Whilst a GFD was associated with histological improvement many patients with newly diagnosed CD had persistent mucosal damage despite many months of gluten restriction. Negative CD serology did not exclude ongoing mucosal injury.